Companion Diagnostic Co-Development

We Build. We Validate. We Deliver.

ResearchDx integrates and aligns IVD and pharma development that simplifies, speeds and ensures delivery of your FDA-approved companion diagnostics.

We Are With You Every Step of the Way.

   

We Are With You Every Step of the Way.

 

Avoid Multi-Partner Outsourcing.

Watch Video

Latest News

Blood-Based Biomarkers Discriminate IBS from IBD with High Degree of Certainty in Patients with Chronic Diarrhea

Brief: Two blood-based biomarkers, cytolethal distending toxin B (CdtB) and anti-vinculin, have been substantively linked with the occurrence of diarrhea-predominant forms of irritable bowel syndrome (IBS). As a result, an ELISA-based diagnostic test developed by Gemelli Biotech is now able to “rule-in” an IBS diagnosis while “ruling-out” irritable bowel disease (IBD) based on elevated biomarker […]

Read More

Association for Molecular Pathology (AMP)

Irvine, CA — July 18, 2019 — ResearchDx will attend the Association of Molecular Pathology (AMP) in Baltimore, Maryland November 7–9, 2019. Please visit our booth or call us at 866.225.9195 or 949.812.6901 to set up a consultation at the show.    

Read More